Is Accenture ACN stock a suitable buy candidate Calm 20260427 Indaptus Therapeutics INDP Stock Is It a Good Entry Point Indaptus Therapeutics misses EPS views no revenue PSBD Palmer rises 272 percent in daily trading despite a steep Q4 2025 EPS miss against analyst estimates